The cost of health care for children and adults with sickle cell disease
- PMID: 19358302
- DOI: 10.1002/ajh.21408
The cost of health care for children and adults with sickle cell disease
Abstract
Although sickle cell disease (SCD) is marked by high utilization of medical resources, the full cost of care for patients with SCD, including care not directly related to SCD, is unknown. The purpose of this study was to estimate the total cost of medical care for a population of children and adults with SCD. We used data from individuals diagnosed with SCD enrolled in the Florida Medicaid program during 2001-2005 to estimate total, SCD-related, and non-SCD-related cost per patient-month based on patient age at the time of health care use. Across the 4,294 patient samples, total health care costs generally rose with age, from $892 to $2,562 per patient-month in the 0-9- and 50-64-year age groups, respectively. Average cost per patient-month was $1,389. Overall, 51.8% of care was directly related to SCD, the majority of which (80.5%) was associated with inpatient hospitalizations. Notably, non-SCD-related costs were substantially higher than those reported for the general US population. These results suggest a discounted (3% discount rate) lifetime cost of care averaging $460,151 per patient with SCD. Interventions designed to prevent SCD complications and avoid hospitalizations may reduce the significant economic burden of the disease.
Comment in
-
The cost of health care for patients with sickle cell disease.Am J Hematol. 2009 Jun;84(6):320-2. doi: 10.1002/ajh.21443. Am J Hematol. 2009. PMID: 19415728 No abstract available.
Similar articles
-
Sickle cell disease-related pediatric medical expenditures in the U.S.Am J Prev Med. 2010 Apr;38(4 Suppl):S550-6. doi: 10.1016/j.amepre.2010.01.004. Am J Prev Med. 2010. PMID: 20331957
-
Health care utilization and expenditures for privately and publicly insured children with sickle cell disease in the United States.Pediatr Blood Cancer. 2009 Oct;53(4):642-6. doi: 10.1002/pbc.22069. Pediatr Blood Cancer. 2009. PMID: 19492318
-
Healthcare utilization and expenditures for low income children with sickle cell disease.Pediatr Blood Cancer. 2009 Feb;52(2):263-7. doi: 10.1002/pbc.21781. Pediatr Blood Cancer. 2009. PMID: 18837428
-
A primary care provider's guide to preventive and acute care management of adults and children with sickle cell disease.J Am Acad Nurse Pract. 2009 May;21(5):250-7. doi: 10.1111/j.1745-7599.2009.00401.x. J Am Acad Nurse Pract. 2009. PMID: 19432908 Review.
-
Transition and sickle cell disease.Pediatrics. 2012 Nov;130(5):926-35. doi: 10.1542/peds.2011-3049. Epub 2012 Oct 1. Pediatrics. 2012. PMID: 23027174 Review.
Cited by
-
Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use.Blood. 2015 Apr 23;125(17):2656-64. doi: 10.1182/blood-2014-06-583351. Epub 2015 Mar 2. Blood. 2015. PMID: 25733584 Free PMC article. Clinical Trial.
-
Drag-reducing polymers improve hepatic vaso-occlusion in SCD mice.Blood Adv. 2020 Sep 22;4(18):4333-4336. doi: 10.1182/bloodadvances.2020002779. Blood Adv. 2020. PMID: 32915976 Free PMC article.
-
A Multiyear Cross-sectional Study of Guideline Adherence for the Timeliness of Opioid Administration in Children With Sickle Cell Pain Crisis.Ann Emerg Med. 2020 Sep;76(3S):S6-S11. doi: 10.1016/j.annemergmed.2020.08.006. Ann Emerg Med. 2020. PMID: 32928464 Free PMC article.
-
Updated mechanisms underlying sickle cell disease-associated pain.Neurosci Lett. 2019 Nov 1;712:134471. doi: 10.1016/j.neulet.2019.134471. Epub 2019 Sep 7. Neurosci Lett. 2019. PMID: 31505241 Free PMC article. Review.
-
Development and validation of the sickle cell stress scale-adult.Eur J Haematol. 2022 Sep;109(3):215-225. doi: 10.1111/ejh.13789. Epub 2022 Jun 3. Eur J Haematol. 2022. PMID: 35585659 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
